Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Barron’s Call for Alibaba’s 50% Downside Seems Misguided

Barron’s has recently published a rather controversial article on Alibaba Group Holding Ltd (NYSE:BABA). In the bearish piece, Barron’s Jonathan Laing wrote that Alibaba could fall by 50%, citing Alibaba’s forward PE of 25 versus eBay Inc (NASDAQ:EBAY)’s 15. Laing also questioned Alibaba’s financial claims, writing that Alibaba’s total number of users of 367 million and its average GMV per user of $1,215 per year did not make any sense given government estimates of China’s online shopping population and China’s low GDP per capita.

Alibaba Group Holding Ltd (NYSE:BABA), alibaba homepage, sign, internet, retail, portal

Gil C /

While poignant, there are some questions over the writer’s assumptions and Alibaba has also issued a response to the Barron’s claims.

In the column, Laing used a forward EPS of $2.56 per share instead of the consensus analyst 2016 EPS estimate of $3.37 per share. If Laing used the consensus EPS estimate, as Alibaba’s response has pointed out, BABA’s forward PE would be 20 instead of 25.

Laing does not give any credit to Alibaba’s future growth. Alibaba’s EPS grew an average of 100% per year for the last five years. Analysts estimate Alibaba’s EPS will grow 24% year over year over the next five years versus eBay Inc (NASDAQ:EBAY)’s 9.5% year-over-year appreciation. Faster growing companies deserve higher valuations. From a growth perspective, Alibaba is cheaper than eBay and its PE will eventually be lower than eBay Inc (NASDAQ:EBAY)’s if analyst predictions pan out.

Laing’s column questions Alibaba Group Holding Ltd (NYSE:BABA) ‘s numbers, hinting that Alibaba numbers aren’t correct. If Alibaba’s numbers aren’t correct, Alibaba should have high short interest. However, currently only 9.8% of Alibaba’s float, or 74 million shares, was short as of August 31, which is not a red flag. There are many other legitimate companies with comparable or larger short floats including Tesla Motors Inc (NASDAQ:TSLA), JD.Com Inc (ADR) (NASDAQ:JD), and Netflix, Inc. (NASDAQ:NFLX).

Furthermore, a who’s who of hedge funds: Soros Fund Management, Appaloosa Management, and Third Point, have all owned significant stakes in Alibaba at one point, although the funds have all sold out because of the large decline. Given that top hedge funds do exhaustive research, the hedge funds would never have invested in Alibaba if the numbers were so obviously incorrect. We mention the hedge fund activity concerning Alibaba because following hedge funds can generate alpha. Our research shows that the 15 most popular small-cap stocks among hedge funds have outperformed the market by nearly a percentage point per month between 1999 and 2012. We have been forward testing the performance of these stock picks since the end of August 2012, and they managed to return more than 118% over the ensuing three years and outperformed the S&P 500 Index by over 60 percentage points.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.